Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 8;12(3):2545-2583.
doi: 10.18632/aging.102762. Epub 2020 Feb 8.

Global burden of larynx cancer, 1990-2017: estimates from the global burden of disease 2017 study

Affiliations

Global burden of larynx cancer, 1990-2017: estimates from the global burden of disease 2017 study

Yujiao Deng et al. Aging (Albany NY). .

Abstract

Larynx cancer is one of the most common cancers in head and neck. This study aimed to investigate the health burden of larynx cancer at global, regional, and national levels. We collected data of larynx cancer between 1990 and 2017 from the Global Burden of Disease study, including incidence, mortality, and disability adjusted life-years (DALYs). Estimated annual percentage changes (EAPCs) were calculated to assess the changes in age-standardized rate (ASR) of larynx cancer. From 1990 to 2017, LC incident cases increased by 58.67%; however, age-standardized incidence rate (ASIR) decreased, with an EAPC of -0.99. Additionally, the incident cases and ASIR of LC were 6-fold higher for male than those for female in 2017. Over the past 28 years, deaths and DALYs of larynx cancer increased by 33.84% and 25%. Contrarily, age-standardized death and DALY rate showed a downward trend. Incidence, death, and DALYs of larynx cancer were always the highest in people aged 50-69 years. Overall, all the ASRs showed downward trends globally. The majority of larynx cancer burden was observed in men, especially among male aged 50-69 years. South and East Asia carried the heaviest burden of larynx cancer worldwide.

Keywords: death; disability adjusted life-years; global burden of disease; incidence; larynx cancer.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST: The authors declare that they have no conflicts of interests.

Figures

Figure 1
Figure 1
The global incidence burden of larynx cancer in 195 countries. (A) The ASIR of larynx cancer in 2017; (B) The relative change in incident cases of larynx cancer between 1990 and 2017; (C) The EAPC of larynx cancer ASIR from 1990 to 2017. Countries with an extreme number of cases/evolution were annotated. ASIR, age-standardized incidence rate; EAPC, estimated annual percentage change.
Figure 2
Figure 2
The EAPC of larynx cancer ASR from 1990 to 2017, by sex and region. (A) The EAPC of ASIR; (B) The EAPC of ASDR; (C) The EAPC of age-standardized DALY rate. ASR: age-standardized rate; ASDR: age standardized death rate; ASIR: age standardized incidence rate; EAPC, estimated annual percentage change; DALY: disability adjusted life-year.
Figure 3
Figure 3
The change trends of age standardized rate among different SDI quintiles and gender from 1990 to 2017. (A) ASIR: age standardized incidence rate; (B) ASDR: age standardized death rate; (C) age-standardized DALY rate. DALY, disability adjusted life-year.
Figure 4
Figure 4
The correlation between EAPC and larynx cancer ASR in 1990 as well as SDI in 2017. The circles represent countries that were available on SDI data. The size of circle is increased with the cases of larynx cancer. The ρ indices and P values presented were derived from Pearson correlation analysis. (A) EAPC and SDI in incidence; (B) EAPC and ASIR; (C) EAPC and SDI in death; (D) EAPC and ASDR; (E) EAPC and SDI in DALYs; (F) EAPC and age-standardized DALY rate. ASIR, age standardized incidence rate; ASDR: age standardized death rate; EAPC, estimated annual percentage change; SDI, socio-demographic index; DALY: disability adjusted life-year.
Figure 5
Figure 5
The proportion of different age groups in larynx cancer by years. (A) incidence, (B) death, (C) DALY. DALY: disability adjusted life-year.
Figure 6
Figure 6
The rate of larynx cancer among gender and age in 1990 and 2017. (A) incidence rate; (B) death rate; (C) DALY rate. DALY, disability adjusted life-year.

References

    1. Steuer CE, El-Deiry M, Parks JR, Higgins KA, Saba NF. An update on larynx cancer. CA Cancer J Clin. 2017; 67:31–50. 10.3322/caac.21386 - DOI - PubMed
    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68:394–424. 10.3322/caac.21492 - DOI - PubMed
    1. Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T, Alizadeh-Navaei R, Allen C, Alsharif U, Alvis-Guzman N, Amini E, Anderson BO, Aremu O, Artaman A, Asgedom SW, et al., and Global Burden of Disease Cancer Collaboration. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2018; 4:1553–68. 10.1001/jamaoncol.2018.2706 - DOI - PMC - PubMed
    1. Perdomo S, Martin Roa G, Brennan P, Forman D, Sierra MS. Head and neck cancer burden and preventive measures in Central and South America. Cancer Epidemiol. 2016. (Suppl 1); 44:S43–52. 10.1016/j.canep.2016.03.012 - DOI - PubMed
    1. Kuper H, Boffetta P, Adami HO. Tobacco use and cancer causation: association by tumour type. J Intern Med. 2002; 252:206–24. 10.1046/j.1365-2796.2002.01022.x - DOI - PubMed

MeSH terms